ArticleTrials2022

Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial.

Cerena Miravalles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.